🔗 Share this article

Acclaimed R&B singer D’Angelo died on October 14 at age 51 after a personal fight with pancreatic cancer.

“The shining star of our household has dimmed his light for us in this life,” his relatives stated. “After a lengthy and brave struggle with cancer, we are deeply saddened to announce that D’Angelo, recognized by his fans around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his innovative neo-soul sound and partnerships with high-profile artists.

He launched his first record, “Brown Sugar,” in 1995 to immediate acclaim. The record reached No. 4 on the R&B charts, went platinum later that year, and earned several award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his music career into the limelight. The record premiered at the top spot on each of Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the public consciousness. The intimate portrayal featured the artist, famously stripped down to his midsection, singing straight into the camera.

D’Angelo retreated from the spotlight after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a serious vehicle accident that left him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with a further No. 1 debut on the R&B chart and a award for Top R&B Record.

Again, in his own enigmatic way, D’Angelo had limited public outings in the following years.

The musician was announced as a headliner for the 2025 Roots Picnic festival, but his performance was canceled, citing an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s health in the months leading up to his death, he had apparently been hospitalized for an extended period and in palliative care for a fortnight.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic malignancy, one of the deadliest and least preventable forms of the illness, on a brilliant talent whose life was cut short.

“We are saddened that he can only provide dear memories with his family, but we are forever thankful for the heritage of deeply emotional music he has left us,” his kin expressed.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic cancer affects the digestive organ, a small organ that produces insulin and is vital in breaking down food, among additional roles. The size and location of the pancreas in the human system make it more difficult to detect malignancy.

Even though pancreatic cancer makes up only approximately three percent of cancer diagnoses each year in the U.S., it is causes 7% of malignancy fatalities.

Nearly seventy thousand individuals will be diagnosed with this condition and roughly 52,000 will succumb to the disease in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have limited and poor therapies, and a smaller window to make a meaningful impact on the lives of patients,” said a medical oncologist.

Since this disease rarely causes initial signs, it’s frequently identified only once the disease is advanced. Although a patient has indicators they are usually nonspecific and may be confused with a several everyday ailments.

“Currently, there is no effective method to identify this malignancy in the early stages, apart from listening to your body and speaking with your doctor if there are unfamiliar signs,” said a health expert.

Frequent indicators of pancreatic cancer include:

• discomfort in the stomach or back
• reduced body mass
• yellowing of skin and eyes
• loss of appetite
• brownish urine
• light-colored or greasy stools
• diarrhea
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s death is an outlier, as pancreatic cancer is typically found in adults in the sixty-five to seventy-five age bracket. However, many cancers, such as this type, have become more common among younger people.

“This disease diagnosed prior to fifty is deemed uncommon, yet alarmingly, doctors are noticing a rising count of younger individuals suffering from this condition,” said a expert.

Family History Impacts Cancer Risk

In the absence of effective screening tools for this malignancy, experts stressed the importance of knowing your family’s cancer history. Some risk factors, such as tobacco use and obesity also have an influence in the onset of pancreatic cancer.

African Americans have the highest incidence of this malignancy in the United States and are most likely to be diagnosed with untreatable disease.

“The initial action toward reducing one’s chance of this condition is assessing personal risk factors. People should review their genetic background, hereditary factors, and medical conditions, such as diabetes, long-term pancreas inflammation, or obesity that may increase their vulnerability,” said a specialist.

Hereditary elements are linked to as much as ten percent of all pancreatic cancer instances. If someone in your family has had pancreatic cancer, you may want to think about genetic testing.

“For individuals with a family history of pancreatic cancer or those carrying elevated risk DNA changes, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to find initial alterations in the pancreas,” he explained.

For those looking to lower their chance, habit adjustments may make a difference. The most effective action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you are a non-smoker, stay away altogether.

Heavy drinking is linked to pancreatitis, a contributing element for pancreatic cancer, so reducing or avoiding alcohol may assist lower your chance.

Controlling your weight or losing weight may also aid decrease your susceptibility. People with excess weight are twenty percent more prone to develop this disease. This malignancy also is more frequent in people with diabetes, and weight loss can also reduce the chance of adult-onset diabetes.

In spite of pancreatic cancer’s poor prognosis, there is still hope.

“We are making progress with treatments and newer combination chemotherapy. There are developing precision medicines that are already making an impact,” remarked a expert.

For many people, however, education about this rare but {dev